Federal health officials have closed the investigation into a multistate infant botulism outbreak linked to powdered infant formula, ending an inquiry that began in June with four hospitalized babies in three states and no deaths. CDC marked the investigation status as closed on August 27 and stated plainly that the outbreak is over.
The more consequential finding is not the closure itself. It is what federal investigators concluded about where the contamination came from. CDC said data indicate "a common source of contamination" linking this outbreak to a larger 2025 outbreak tied to a different brand of powdered formula.
That is the sentence parents should carry forward. Two separate formula brands, two separate outbreaks months apart, and one shared upstream supply problem that standard industry practice did not catch before infants were hurt.
A Closed File with One Open Warning for Households
Powdered infant formula has a long shelf life, and the CDC used the closure notice to repeat a caution that outlasts the investigation. Any recalled Nara Organics Whole Milk Organic Infant Formula still sitting in a cabinet should not be fed to an infant and should be discarded.
Nara Organics recalled all lots of the product on June 13. It had been sold at Target retail stores, on Target.com, and on Nara.com. Because families buy formula in bulk and store it for months, an unopened can from last spring can still be in a home long after news coverage ends. The recall notice covers every lot number and both can sizes.
Items and surfaces that touched the recalled formula should be washed with hot soapy water or run through a dishwasher, according to the CDC outbreak page.
The Final Count and What Infant Botulism Looks Like
The closed investigation lists four cases, four hospitalizations, zero deaths, and three states: California, Pennsylvania, and Washington. All were toxin type A infections with illness onsets between April and May, according to the FDA outbreak investigation page. BabyBIG, the treatment recommended for all suspected cases, is available through the Infant Botulism Treatment and Prevention Program at the California Department of Public Health.
Four cases sound small for a national investigation, and the explanation is in the clinical picture rather than the count. Infant botulism occurs when Clostridium botulinum spores are swallowed and produce toxin inside a baby's immature digestive system. The toxin attacks the nervous system and causes progressive muscle weakness that can lead to respiratory failure and weeks of hospitalization if untreated.
The early signs are quiet and easy to attribute to something else. CDC lists poor feeding, loss of head control, difficulty swallowing, and decreased facial expression. Constipation is often the first change parents notice. None of these looks like an emergency at first glance, which is exactly why a small number of confirmed cases justified a federal investigation.
Clinicians are advised to begin treatment on clinical suspicion without waiting for laboratory confirmation, because delay increases the risk of respiratory failure. The treatment program takes consultation calls at any hour.
A Supplier Pattern That Regulators Had Not Been Looking For
The 2025 outbreak referenced in the CDC's conclusion involved ByHeart Whole Nutrition Infant Formula and sickened 48 infants across 17 states from late 2025 through early 2026. That investigation closed in February.
FDA traced the Nara Organics lots linked to illness to milk supplied by Organic West Milk and spray dried by Dairy Farmers of America, the same suppliers involved in the ByHeart outbreak. The agency has been more cautious than the CDC in its own language, saying there is "not enough evidence to determine if this is the source" or route of contamination, and its root cause work continues.
One detail explains a great deal about how a second outbreak followed the first. During the 2025 investigation, the FDA asked Organic West Milk which other formula manufacturers it supplied. The company provided an incomplete customer list that did not include the manufacturers of Nara Organics formula, and only disclosed the omission during the current investigation.
FDA has published post-outbreak response activities describing what it is doing next. The agency now treats Clostridium botulinum as an emerging risk in infant formula production, has asked international scientific bodies to reassess spore-forming pathogens in powdered formula, and sent a letter to the infant formula industry urging closer scrutiny of ingredients and ingredient sources. No new federal testing requirement has been finalized.
Monitoring Windows, Costs, and What Comes Next
Symptoms of infant botulism can take as long as several weeks to develop. CDC advises parents whose infants consumed the recalled formula to watch for symptoms for a full month after the last feeding. For families who stopped using the product in June, that window has closed. For anyone who used a stored can more recently, it has not.
An infant showing poor feeding, a weak cry, loss of head control, difficulty swallowing, or reduced facial expression needs immediate medical evaluation. Parents should not wait for a diagnosis to seek care.
Cost is a real barrier for formula families, and switching brands mid-recall is expensive. Families enrolled in WIC can ask their local agency about approved substitutions, and pediatric practices often hold manufacturer samples. CDC advises photographing the label, lot number, and use-by date of any leftover formula before discarding it, which also helps with refund and return requests.
The investigation is closed, the case count is final at four, and the recalled product should be thrown away rather than used. What remains unresolved is whether federal testing expectations for powdered infant formula will change now that two outbreaks in under a year have been traced to the same suppliers.
Key Questions Answered
Is the outbreak over? Yes. CDC marked the investigation closed on August 27 and stated the outbreak is over. The final count is four cases, four hospitalizations, and no deaths across three states.
Should recalled formula still be thrown away? Yes. Powdered formula has a long shelf life, and the CDC advises discarding any recalled Nara Organics formula still in the home rather than feeding it to an infant.
What connects this to the 2025 outbreak? CDC said data indicate a common source of contamination between this outbreak and the 2025 outbreak linked to ByHeart formula. FDA traced both to the same milk supplier and processor.
What are the symptoms of infant botulism? Poor feeding, loss of head control, difficulty swallowing, and decreased facial expression. Constipation is often the earliest change. Symptoms can take weeks to appear.
How long should parents monitor? CDC advises watching for symptoms for one month after an infant last consumed the recalled product.
Is there a treatment? Yes. BabyBIG is recommended for all suspected cases and is available through the Infant Botulism Treatment and Prevention Program at the California Department of Public Health. Clinicians are advised to begin treatment on suspicion rather than waiting for confirmation.
Has federal testing policy changed? Not yet. FDA now describes Clostridium botulinum as an emerging risk in infant formula production and has asked international bodies to reassess it, but no new requirement has been finalized.
